Ultrasound molecular imaging of endothelial cell activation and damage in atherosclerosis

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Atherosclerosis is a gradual process that evolves over decades with variable plaque morphologies that can lead to atherothrombotic complications such as stroke and acute coronary syndromes. The ability to image the structural, cellular, or biochemical signatures of high-risk plaque phenotype has been a major goal for essentially all forms of clinical and preclinical imaging. These efforts have been based on the need to better understand pathobiology, the need to have a biologic readout for the testing of efficacy for new treatment strategies, and for the clinical purposes of potentially selecting patients for more aggressive forms of anti-atherosclerotic treatments that are in development stage. Ultrasoundbased evaluation of plaque severity and plaque composition is already an integral part of the practice of cardiovascular medicine in the form of extracorporeal and intravascular imaging. New ultrasound-based techniques are being developed that may provide incremental information to structure alone. Some of these techniques are based on the ability to detect vascular inflammation by either regional abnormalities in the mechanical properties of the vessel wall or presence of plaque neovessels using contrast ultrasound imaging. Molecular imaging with acoustically active agents targeted to endothelial cell adhesion molecules, platelets, and microthrombosis has also been used to evaluate high-risk phenotype. Although clinical translation is a distant goal, the impact of ultrasound-based molecular imaging is already being felt through its application to better define pathophysiology and evaluate new therapies in atherosclerotic disease.

Original languageEnglish (US)
Title of host publicationCardiovascular Imaging: Arterial and Aortic Valve Inflammation and Calcification
PublisherSpringer International Publishing
Pages39-64
Number of pages26
ISBN (Print)9783319092683, 9783319092676
DOIs
StatePublished - Jan 1 2015

Fingerprint

Molecular imaging
Molecular Imaging
Endothelial cells
Ultrasonography
Atherosclerosis
Endothelial Cells
Ultrasonics
Chemical activation
Phenotype
Imaging techniques
Cell Adhesion Molecules
Acute Coronary Syndrome
Blood Vessels
Blood Platelets
Stroke
Medicine
Platelets
Inflammation
Therapeutics
Mechanical properties

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Atkinson, T. T., & Lindner, J. (2015). Ultrasound molecular imaging of endothelial cell activation and damage in atherosclerosis. In Cardiovascular Imaging: Arterial and Aortic Valve Inflammation and Calcification (pp. 39-64). Springer International Publishing. https://doi.org/10.1007/978-3-319-09268-3_2

Ultrasound molecular imaging of endothelial cell activation and damage in atherosclerosis. / Atkinson, Tamara (Tami); Lindner, Jonathan.

Cardiovascular Imaging: Arterial and Aortic Valve Inflammation and Calcification. Springer International Publishing, 2015. p. 39-64.

Research output: Chapter in Book/Report/Conference proceedingChapter

Atkinson, TT & Lindner, J 2015, Ultrasound molecular imaging of endothelial cell activation and damage in atherosclerosis. in Cardiovascular Imaging: Arterial and Aortic Valve Inflammation and Calcification. Springer International Publishing, pp. 39-64. https://doi.org/10.1007/978-3-319-09268-3_2
Atkinson TT, Lindner J. Ultrasound molecular imaging of endothelial cell activation and damage in atherosclerosis. In Cardiovascular Imaging: Arterial and Aortic Valve Inflammation and Calcification. Springer International Publishing. 2015. p. 39-64 https://doi.org/10.1007/978-3-319-09268-3_2
Atkinson, Tamara (Tami) ; Lindner, Jonathan. / Ultrasound molecular imaging of endothelial cell activation and damage in atherosclerosis. Cardiovascular Imaging: Arterial and Aortic Valve Inflammation and Calcification. Springer International Publishing, 2015. pp. 39-64
@inbook{ebb267dc638f4db582e92e16071c6b46,
title = "Ultrasound molecular imaging of endothelial cell activation and damage in atherosclerosis",
abstract = "Atherosclerosis is a gradual process that evolves over decades with variable plaque morphologies that can lead to atherothrombotic complications such as stroke and acute coronary syndromes. The ability to image the structural, cellular, or biochemical signatures of high-risk plaque phenotype has been a major goal for essentially all forms of clinical and preclinical imaging. These efforts have been based on the need to better understand pathobiology, the need to have a biologic readout for the testing of efficacy for new treatment strategies, and for the clinical purposes of potentially selecting patients for more aggressive forms of anti-atherosclerotic treatments that are in development stage. Ultrasoundbased evaluation of plaque severity and plaque composition is already an integral part of the practice of cardiovascular medicine in the form of extracorporeal and intravascular imaging. New ultrasound-based techniques are being developed that may provide incremental information to structure alone. Some of these techniques are based on the ability to detect vascular inflammation by either regional abnormalities in the mechanical properties of the vessel wall or presence of plaque neovessels using contrast ultrasound imaging. Molecular imaging with acoustically active agents targeted to endothelial cell adhesion molecules, platelets, and microthrombosis has also been used to evaluate high-risk phenotype. Although clinical translation is a distant goal, the impact of ultrasound-based molecular imaging is already being felt through its application to better define pathophysiology and evaluate new therapies in atherosclerotic disease.",
author = "Atkinson, {Tamara (Tami)} and Jonathan Lindner",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-319-09268-3_2",
language = "English (US)",
isbn = "9783319092683",
pages = "39--64",
booktitle = "Cardiovascular Imaging: Arterial and Aortic Valve Inflammation and Calcification",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Ultrasound molecular imaging of endothelial cell activation and damage in atherosclerosis

AU - Atkinson, Tamara (Tami)

AU - Lindner, Jonathan

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Atherosclerosis is a gradual process that evolves over decades with variable plaque morphologies that can lead to atherothrombotic complications such as stroke and acute coronary syndromes. The ability to image the structural, cellular, or biochemical signatures of high-risk plaque phenotype has been a major goal for essentially all forms of clinical and preclinical imaging. These efforts have been based on the need to better understand pathobiology, the need to have a biologic readout for the testing of efficacy for new treatment strategies, and for the clinical purposes of potentially selecting patients for more aggressive forms of anti-atherosclerotic treatments that are in development stage. Ultrasoundbased evaluation of plaque severity and plaque composition is already an integral part of the practice of cardiovascular medicine in the form of extracorporeal and intravascular imaging. New ultrasound-based techniques are being developed that may provide incremental information to structure alone. Some of these techniques are based on the ability to detect vascular inflammation by either regional abnormalities in the mechanical properties of the vessel wall or presence of plaque neovessels using contrast ultrasound imaging. Molecular imaging with acoustically active agents targeted to endothelial cell adhesion molecules, platelets, and microthrombosis has also been used to evaluate high-risk phenotype. Although clinical translation is a distant goal, the impact of ultrasound-based molecular imaging is already being felt through its application to better define pathophysiology and evaluate new therapies in atherosclerotic disease.

AB - Atherosclerosis is a gradual process that evolves over decades with variable plaque morphologies that can lead to atherothrombotic complications such as stroke and acute coronary syndromes. The ability to image the structural, cellular, or biochemical signatures of high-risk plaque phenotype has been a major goal for essentially all forms of clinical and preclinical imaging. These efforts have been based on the need to better understand pathobiology, the need to have a biologic readout for the testing of efficacy for new treatment strategies, and for the clinical purposes of potentially selecting patients for more aggressive forms of anti-atherosclerotic treatments that are in development stage. Ultrasoundbased evaluation of plaque severity and plaque composition is already an integral part of the practice of cardiovascular medicine in the form of extracorporeal and intravascular imaging. New ultrasound-based techniques are being developed that may provide incremental information to structure alone. Some of these techniques are based on the ability to detect vascular inflammation by either regional abnormalities in the mechanical properties of the vessel wall or presence of plaque neovessels using contrast ultrasound imaging. Molecular imaging with acoustically active agents targeted to endothelial cell adhesion molecules, platelets, and microthrombosis has also been used to evaluate high-risk phenotype. Although clinical translation is a distant goal, the impact of ultrasound-based molecular imaging is already being felt through its application to better define pathophysiology and evaluate new therapies in atherosclerotic disease.

UR - http://www.scopus.com/inward/record.url?scp=84944548462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944548462&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-09268-3_2

DO - 10.1007/978-3-319-09268-3_2

M3 - Chapter

AN - SCOPUS:84944548462

SN - 9783319092683

SN - 9783319092676

SP - 39

EP - 64

BT - Cardiovascular Imaging: Arterial and Aortic Valve Inflammation and Calcification

PB - Springer International Publishing

ER -